Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 104

    1.

    Amplified hormonal counterregulatory responses to hypoglycemia in rats after systemic delivery of a SUR-1-selective K(+) channel opener?

    Fan X, Ding Y, Cheng H, Gram DX, Sherwin RS, McCrimmon RJ.

    Diabetes. 2008 Dec;57(12):3327-34. Epub 2008 Sep 5.PMID: 18776135 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Activation of ATP-sensitive K+ channels in the ventromedial hypothalamus amplifies counterregulatory hormone responses to hypoglycemia in normal and recurrently hypoglycemic rats.

    McCrimmon RJ, Evans ML, Fan X, McNay EC, Chan O, Ding Y, Zhu W, Gram DX, Sherwin RS.

    Diabetes. 2005 Nov;54(11):3169-74.PMID: 16249441 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Attenuation of hyperinsulinemia by NN414, a SUR1/Kir6.2 selective K-adenosine triphosphate channel opener, improves glucose tolerance and lipid profile in obese Zucker rats.

    Alemzadeh R, Fledelius C, Bodvarsdottir T, Sturis J.

    Metabolism. 2004 Apr;53(4):441-7.PMID: 15045689 [PubMed - indexed for MEDLINE]Related articles

    5.

    NN414, a SUR1/Kir6.2-selective potassium channel opener, reduces blood glucose and improves glucose tolerance in the VDF Zucker rat.

    Carr RD, Brand CL, Bodvarsdottir TB, Hansen JB, Sturis J.

    Diabetes. 2003 Oct;52(10):2513-8.PMID: 14514634 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    The effects of NN414, a SUR1/Kir6.2 selective potassium channel opener, in healthy male subjects.

    Zdravkovic M, Kruse M, Rost KL, Møss J, Kecskes A, Dyrberg T.

    J Clin Pharmacol. 2005 Jul;45(7):763-72.PMID: 15951466 [PubMed - indexed for MEDLINE]Related articles

    7.

    Potent and selective activation of the pancreatic beta-cell type K(ATP) channel by two novel diazoxide analogues.

    Dabrowski M, Larsen T, Ashcroft FM, Bondo Hansen J, Wahl P.

    Diabetologia. 2003 Oct;46(10):1375-82. Epub 2003 Sep 5.PMID: 12961066 [PubMed - indexed for MEDLINE]Related articles

    8.

    Improved beta-cell survival and reduced insulitis in a type 1 diabetic rat model after treatment with a beta-cell-selective K(ATP) channel opener.

    Skak K, Gotfredsen CF, Lundsgaard D, Hansen JB, Sturis J, Markholst H.

    Diabetes. 2004 Apr;53(4):1089-95.PMID: 15047626 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Hypothalamic ATP-sensitive K + channels play a key role in sensing hypoglycemia and triggering counterregulatory epinephrine and glucagon responses.

    Evans ML, McCrimmon RJ, Flanagan DE, Keshavarz T, Fan X, McNay EC, Jacob RJ, Sherwin RS.

    Diabetes. 2004 Oct;53(10):2542-51.PMID: 15448082 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Towards selective Kir6.2/SUR1 potassium channel openers, medicinal chemistry and therapeutic perspectives.

    Hansen JB.

    Curr Med Chem. 2006;13(4):361-76. Review.PMID: 16475928 [PubMed - indexed for MEDLINE]Related articles

    12.

    ATP-sensitive K(+) channels regulate the release of GABA in the ventromedial hypothalamus during hypoglycemia.

    Chan O, Lawson M, Zhu W, Beverly JL, Sherwin RS.

    Diabetes. 2007 Apr;56(4):1120-6. Epub 2007 Jan 24.PMID: 17251273 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Uncoupling by (--)-epigallocatechin-3-gallate of ATP-sensitive potassium channels from phosphatidylinositol polyphosphates and ATP.

    Jin JY, Park SH, Bae JH, Cho HC, Lim JG, Park WS, Han J, Lee JH, Song DK.

    Pharmacol Res. 2007 Sep;56(3):237-47. Epub 2007 Jun 21.PMID: 17656102 [PubMed - indexed for MEDLINE]Related articles

    14.

    New 3-alkylamino-4H-thieno-1,2,4-thiadiazine 1,1-dioxide derivatives activate ATP-sensitive potassium channels of pancreatic beta cells.

    Nielsen FE, Ebdrup S, Jensen AF, Ynddal L, Bodvarsdottir TB, Stidsen C, Worsaae A, Boonen HC, Arkhammar PO, Fremming T, Wahl P, Kornø HT, Hansen JB.

    J Med Chem. 2006 Jul 13;49(14):4127-39.PMID: 16821773 [PubMed - indexed for MEDLINE]Related articles

    16.

    Lipids modulate ligand binding to sulphonylurea receptors.

    Klein A, Lichtenberg J, Stephan D, Quast U.

    Br J Pharmacol. 2005 Aug;145(7):907-15.PMID: 15895108 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Iptakalim modulates ATP-sensitive K(+) channels in dopamine neurons from rat substantia nigra pars compacta.

    Wu J, Hu J, Chen YP, Takeo T, Suga S, Dechon J, Liu Q, Yang KC, St John PA, Hu G, Wang H, Wakui M.

    J Pharmacol Exp Ther. 2006 Oct;319(1):155-64. Epub 2006 Jul 12.PMID: 16837559 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The effects of NN414, a SUR1/Kir6.2 selective potassium channel opener in subjects with type 2 diabetes.

    Zdravkovic M, Kruse M, Rost KL, Møss J, Kecskes A.

    Exp Clin Endocrinol Diabetes. 2007 Jun;115(6):405-6.PMID: 17701889 [PubMed - indexed for MEDLINE]Related articles

    20.

    ABCC8 and ABCC9: ABC transporters that regulate K+ channels.

    Bryan J, Muñoz A, Zhang X, Düfer M, Drews G, Krippeit-Drews P, Aguilar-Bryan L.

    Pflugers Arch. 2007 Feb;453(5):703-18. Epub 2006 Aug 8. Review.PMID: 16897043 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data